Where can researchers source third-party tested Melanotan I?

Midwest Peptide supplies research-grade Melanotan I with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Memorial Day: 15% off code MEMDAY15Memorial Day Sale — 15% off site-wide with code MEMDAY15

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

Melanotan I vs Melanotan II Research | Midwest Peptide

Melanotan II in Research: A Literature Review of Melanocortin Agonist StudiesPrev|Afamelanotide EPP Research: Clinical Literature ReviewNext

Melanotan I vs Melanotan II: Receptor Selectivity Comparison in Research

Q: Is Melanotan I approved for human use?

No. Melanotan I is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Melanotan I · Published April 9, 2026 · Updated May 18, 2026 · 8 min read

Quick Answer

Melanotan I and Melanotan II differ in structure (linear vs cyclic) and receptor selectivity (MC1R-selective vs broad melanocortin). This comparison covers structural differences, receptor binding profiles across MC1R/MC3R/MC4R/MC5R, and research applications for each peptide in melanocortin pharmacology. For research use only, not for human consumption.

Melanotan I vs Melanotan II: Receptor Selectivity Comparison in Research

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

Two Synthetic Alpha-MSH Analogs
Structural Comparison
Receptor Selectivity Comparison
Research Applications Compared
Pigmentation Effects Compared
Practical Considerations for Research Selection
Open Research Questions
Conclusion
Related Research Articles
Explore Related Products
Frequently Asked Questions
Glossary

Melanotan I vs Melanotan II research provides essential comparative context for investigators selecting melanocortin receptor agonists for preclinical studies. Both peptides emerged from the same University of Arizona research program in the 1980s and are synthetic analogs of alpha-MSH, but they have distinct structural features and different receptor selectivity profiles that make them appropriate for different research questions. As the comparative review component of the Melanotan I research cluster, this article reviews the published literature on how Melanotan I and Melanotan II compare with each other in research models.

Frequently Asked Questions

What is Melanotan I in research contexts?

Melanotan I (afamelanotide) is a synthetic 13-amino-acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH) with high MC1R selectivity. It is studied in preclinical research and clinical literature for melanogenesis, photoprotection, and erythropoietic protoporphyria.

How do Melanotan I and Melanotan II differ structurally?

Melanotan I is a 13-amino-acid linear analog of alpha-MSH with high MC1R selectivity. Melanotan II is a cyclic 7-amino-acid peptide with a disulfide-replaced cyclic backbone that broadens binding to MC1R, MC3R, MC4R, and MC5R, producing additional central effects.

Which is preferred for which research questions?

Melanotan I is preferred when selective MC1R activation for pigmentation or photoprotection is desired. Melanotan II is preferred when central melanocortin effects (food intake, sexual behavior) or broader receptor engagement are the research focus.

Is Melanotan I approved for human use?

Glossary

Key terms used in this article.

MC1R: Melanocortin 1 receptor, the primary GPCR on melanocytes that signals melanin synthesis upon alpha-MSH binding.
Melanogenesis: The biochemical pathway producing melanin from tyrosine within melanosomes of melanocytes.
Eumelanin: The dark brown to black melanin pigment that provides photoprotective absorbance of UV radiation.
Tyrosinase: The rate-limiting copper-dependent enzyme catalyzing the first two steps of melanin biosynthesis from tyrosine.
Erythropoietic Protoporphyria (EPP): A rare genetic disorder of heme biosynthesis causing severe photosensitivity, the indication for clinical afamelanotide use.
MC4R: Melanocortin 4 receptor, primarily expressed in the hypothalamus and central nervous system, regulating appetite and sexual behavior.
MC5R: Melanocortin 5 receptor, broadly distributed and implicated in exocrine function and lipolysis.
Cyclic Peptide: A peptide whose backbone or side chains are joined into a ring, conferring increased stability and receptor selectivity.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

For Research Use Only. Melanotan I and Melanotan II are intended exclusively for in vitro and preclinical research. They are not approved for human use, are not drugs, and should never be administered to humans or to animals outside of an authorized research protocol.

Two Synthetic Alpha-MSH Analogs

Melanotan I and Melanotan II both emerged from the academic research program on melanocortin receptor pharmacology at the University of Arizona in the 1980s, led by Mac Hadley, Victor Hruby, and colleagues. The original research interest was in characterizing structure activity relationships in alpha-melanocyte stimulating hormone (alpha-MSH) and developing stable synthetic analogs that could be used as research tools for melanocortin signaling studies.

Both Melanotan I and Melanotan II are synthetic analogs of alpha-MSH that incorporate amino acid substitutions to confer increased stability against enzymatic degradation. However, they differ substantially in their structural features and in their receptor selectivity profiles, making them distinct research tools despite their common origin.

Melanotan I is a linear synthetic analog of alpha-MSH with high selectivity for the MC1R receptor. It is the international nonproprietary name for afamelanotide, which has been studied in clinical research for erythropoietic protoporphyria (EPP). For more on the EPP research, see our companion article on Afamelanotide EPP research and clinical literature review.

Melanotan II is a cyclic synthetic analog of alpha-MSH with broader activity at multiple melanocortin receptors (MC1R, MC3R, MC4R, MC5R). The cyclic structure includes a lactam bridge between two amino acids that contributes to its stability and to its receptor binding profile. Melanotan II has been studied for both pigmentation and central nervous system effects in research models.

Structural Comparison

The structures of Melanotan I and Melanotan II illustrate two different approaches to designing stable alpha-MSH analogs.

Melanotan I is a linear peptide based on the alpha-MSH(4-13) sequence with amino acid substitutions designed to improve stability while preserving MC1R selectivity. The linear structure means that the peptide adopts an extended conformation in solution that is similar to that of natural alpha-MSH, which contributes to its receptor binding profile.

Melanotan II is a cyclic peptide that incorporates a lactam bridge between two amino acid side chains, creating a closed structure that stabilizes the peptide and constrains its conformation. The cyclization is one of the more important design features of Melanotan II because it provides significant stability against enzymatic degradation and contributes to the broader receptor activity profile compared to the linear Melanotan I.

The different structural approaches reflect different design philosophies. Melanotan I aimed for high MC1R selectivity through targeted amino acid substitutions, while Melanotan II aimed for broader activity through cyclization that opened up additional receptor binding modes.

Receptor Selectivity Comparison

Receptor selectivity is the most important practical difference between Melanotan I and Melanotan II for research applications.

Melanotan I has high selectivity for MC1R, with much lower binding affinity at MC3R, MC4R, and MC5R. This selectivity makes Melanotan I appropriate for research questions that require activation of MC1R specifically, without confounding effects from other melanocortin receptors. The selectivity is particularly important for pigmentation research, where MC1R is the main receptor of interest and broader receptor activation could complicate interpretation of findings.

Melanotan II has broader activity across the melanocortin receptor family, with measurable binding at MC1R, MC3R, MC4R, and MC5R. This non-selective profile makes Melanotan II appropriate for research questions that aim to characterize the broader melanocortin signaling system or that benefit from simultaneous activation of multiple receptors. The broader activity has been particularly relevant for research on central nervous system melanocortin signaling, where MC3R and MC4R play important roles in addition to peripheral MC1R.

The receptor selectivity differences between Melanotan I and Melanotan II are well characterized in research literature and provide a clear basis for selecting between the two peptides for specific experimental questions. For more on the MC1R receptor specifically, see our companion article on MC1R receptor research and the target of Melanotan I.

Research Applications Compared

The research applications of Melanotan I and Melanotan II reflect their different selectivity profiles.

Melanotan I research applications include studies of:

MC1R-specific effects on melanogenesis in research models
Pigmentation research where MC1R selectivity is required
Clinical research in erythropoietic protoporphyria (EPP)
Reference compound for MC1R selective agonist comparisons

Melanotan II research applications include studies of:

Broader melanocortin receptor signaling research
MC3R and MC4R-mediated effects in central nervous system research
Combined effects across multiple melanocortin receptors
Reference compound for non-selective melanocortin agonist research

The complementary nature of these research applications means that Melanotan I and Melanotan II are sometimes used together in research designs that aim to characterize both selective and non-selective melanocortin receptor activation. The combination provides a useful pharmacological dissection tool for the melanocortin system.

Pigmentation Effects Compared

Both Melanotan I and Melanotan II produce pigmentation effects in research models through MC1R activation, but the relative magnitude and time course can differ between the two peptides.

Melanotan I, with its high MC1R selectivity, produces pigmentation effects through this single receptor pathway. The effects are well characterized in research models and provide a clean measurement of MC1R-mediated melanogenesis without confounding effects from other melanocortin receptors.

Melanotan II also produces pigmentation effects through MC1R activation, but its broader receptor profile means that the overall biological response includes contributions from MC3R, MC4R, and MC5R activation in addition to the MC1R-mediated melanogenesis. This broader profile can produce different overall outcomes in some research contexts, particularly in studies that examine multiple endpoints simultaneously.

For more on the pigmentation research with Melanotan I, see our companion article on Melanotan I melanogenesis research and pigmentation studies.

Practical Considerations for Research Selection

The choice between Melanotan I and Melanotan II for specific research applications depends on several practical considerations.

For research questions requiring MC1R selectivity, Melanotan I is the more appropriate research tool. Its high selectivity allows researchers to attribute observed effects to MC1R signaling without ambiguity from other receptor activation.

For research questions about broader melanocortin signaling, Melanotan II is the more appropriate research tool. Its non-selective profile allows for activation of multiple receptors simultaneously, which is useful for studies that aim to characterize the integrated melanocortin system.

For pigmentation research specifically, both peptides can be used, with Melanotan I providing cleaner pharmacological interpretation due to its MC1R selectivity. Melanotan II may be appropriate for pigmentation studies that also examine effects on other systems where its broader receptor activity is relevant.

The choice between the two peptides depends on the experimental question rather than on inherent superiority of one over the other.

Open Research Questions

Several open research questions remain in the comparative Melanotan I vs Melanotan II literature. These include how the structural differences between linear and cyclic alpha-MSH analogs affect their tissue distribution and clearance pathways in research models, how the receptor selectivity differences translate quantitatively to functional differences in research models with multiple potential melanocortin receptor effects, and how the two peptides compare in head to head studies of specific endpoints. Each of these is a legitimate research opportunity for investigators studying melanocortin pharmacology.

Conclusion

Melanotan I vs Melanotan II research provides essential comparative context for investigators selecting melanocortin receptor agonists for preclinical studies. The two peptides share a common origin but have distinct structural features (linear vs cyclic) and different receptor selectivity profiles (MC1R selective vs non-selective) that make them appropriate for different research questions. For investigators using MT-1 10mg as a research tool, the comparative literature provides the broader landscape against which the specific properties of Melanotan I can be evaluated.

For more on the full Melanotan I research cluster, see the pillar overview article and the supporting articles on each major topic.

Melanotan I and Melanotan II are supplied by Midwest Peptide for research use only and are not intended for human administration.

Explore more peer-reviewed research and laboratory guides from our science team:

All products are third-party tested with a Certificate of Analysis (COA) included. For research use only.

MT-1 10mg, 99%+ purity, COA included
MT-2 10mg, 99%+ purity, COA included
GHK-Cu 50mg, 99%+ purity, COA included

Browse All Research Peptides →

Age Verification

Melanotan I vs Melanotan II: Receptor Selectivity Comparison in Research

Frequently Asked Questions

What is Melanotan I in research contexts?

How do Melanotan I and Melanotan II differ structurally?

Which is preferred for which research questions?

Is Melanotan I approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

Two Synthetic Alpha-MSH Analogs

Structural Comparison

Receptor Selectivity Comparison

Research Applications Compared

Pigmentation Effects Compared

Practical Considerations for Research Selection

Open Research Questions

Conclusion

Ready to Start Your Research?

Where can researchers source third-party tested Melanotan I?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?

Age Verification

Melanotan I vs Melanotan II: Receptor Selectivity Comparison in Research

Frequently Asked Questions

What is Melanotan I in research contexts?

How do Melanotan I and Melanotan II differ structurally?

Which is preferred for which research questions?

Is Melanotan I approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

Two Synthetic Alpha-MSH Analogs

Structural Comparison

Receptor Selectivity Comparison

Research Applications Compared

Pigmentation Effects Compared

Practical Considerations for Research Selection

Open Research Questions

Conclusion

Related Research Articles

Explore Related Products

Ready to Start Your Research?

Where can researchers source third-party tested Melanotan I?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?